Whitehawk Therapeutics (WHWK) Research & Development (2018 - 2025)
Historic Research & Development for Whitehawk Therapeutics (WHWK) over the last 7 years, with Q3 2025 value amounting to $14.3 million.
- Whitehawk Therapeutics' Research & Development rose 4349.3% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.3 million, marking a year-over-year increase of 7449.39%. This contributed to the annual value of $51.0 million for FY2024, which is 429.4% up from last year.
- Whitehawk Therapeutics' Research & Development amounted to $14.3 million in Q3 2025, which was up 4349.3% from $48.8 million recorded in Q2 2025.
- In the past 5 years, Whitehawk Therapeutics' Research & Development registered a high of $48.8 million during Q2 2025, and its lowest value of $3.0 million during Q2 2021.
- For the 5-year period, Whitehawk Therapeutics' Research & Development averaged around $11.8 million, with its median value being $10.0 million (2024).
- Over the last 5 years, Whitehawk Therapeutics' Research & Development had its largest YoY gain of 27278.7% in 2025, and its largest YoY loss of 3534.91% in 2025.
- Whitehawk Therapeutics' Research & Development (Quarter) stood at $7.2 million in 2021, then rose by 29.65% to $9.4 million in 2022, then soared by 36.26% to $12.8 million in 2023, then rose by 12.37% to $14.3 million in 2024, then decreased by 0.01% to $14.3 million in 2025.
- Its Research & Development was $14.3 million in Q3 2025, compared to $48.8 million in Q2 2025 and $8.8 million in Q1 2025.